Karnofsky Performance Scale in Hospice and Palliative Care

The Karnofsky Performance Scale (KPS) is a staple in clinical documentation for patients facing serious illness. While it originated in oncology research, its utility has expanded into broader palliative and hospice care settings. It provides a structured method to describe how a disease impacts a patient's daily activity, self-care abilities, and requirement for medical intervention. ^1,2 For clinical teams managing care transitions and documentation, this shared language supports clearer communication and more accurate prognostic planning.

This article examines the mechanics of the Karnofsky Performance Scale, how to apply its scoring system, and its specific role in hospice and palliative care. We will also compare it to the Palliative Performance Scale (PPS) and provide practical examples of how a downloadable reference tool can improve accuracy across your interdisciplinary team.

What Is the Karnofsky Performance Scale?

The Karnofsky Performance Scale, frequently referred to as KPS, is a clinician-rated assessment used to measure a patient's ability to perform ordinary tasks.¹ The scale uses a range from 100 to 0, moving in 10-point increments. A higher score represents a greater level of independence, while a lower score indicates a need for increased assistance and a higher degree of functional decline.¹

The scale is organized into three primary categories:

• 100–80: The patient is able to carry on normal activity and work. No special care is needed.

• 70–50: The patient is unable to work but can live at home and care for most personal needs. Varying degrees of assistance are required.

• 40–0: The patient is unable to care for themselves and requires the equivalent of institutional or hospital care. Disease may be progressing quickly.^1,3

The value of the KPS lies in its straightforward nature. Instead of a lengthy checklist, clinicians can summarize a patient’s status in a single number. This score helps track functional changes over time and aids in discussions regarding prognosis when combined with clinical factors like symptom burden and nutritional status.^2,4

How the Scoring Works in Clinical Practice

KPS uses 11 discrete levels to define a patient’s functional status. While specific wording can vary slightly between healthcare settings, the core definitions remain the same.¹

The Higher Range (80–100)

A score of 100 indicates normal function with no evidence of disease. At 80, the patient can perform normal activities with some effort, perhaps showing minor signs or symptoms of their condition.

The Middle Range (50–70)

A score of 70 is a frequent tipping point; the patient can care for themselves but cannot maintain normal work or active social roles. At 50, the patient requires considerable assistance and frequent medical care.^1,5

The Lower Range (0–40)

At 40, the patient is disabled and requires special care and assistance. Scores continue to drop as the patient becomes bedbound, eventually reaching 0, which signifies death.^1,5

A primary reason the Karnofsky Performance Scale remains a standard is its focus on observable function. Patients may not understand their lab values, but they recognize when they can no longer dress themselves or when walking to the kitchen becomes a struggle. The KPS translates these life changes into objective data points.^1,2

Evidence indicates that the KPS has acceptable reliability, but team consistency depends on shared definitions.^6,7 Using a standard reference document or a PDF guide can help different clinicians, such as nurses, therapists, and social workers, arrive at the same score for the same patient.

The Role of KPS in Hospice and Palliative Care

In end-of-life care, functional status is tied to care planning and support requirements.^2,4 Lower performance scores are often associated with shorter survival times, making the KPS a helpful data point when discussing goals of care.^5,7

Regulatory and Documentation Requirements

CMS guidelines for hospice include functional impairment as a component of terminal status. In many Medicare Local Coverage Determinations (LCDs), a Karnofsky Performance Scale score of 70% or below is cited as a supporting factor for hospice eligibility, particularly when paired with dependence in two or more activities of daily living (ADLs).³

It is important to note that the KPS is not a standalone gatekeeper for care. It should be used as one piece of a broader assessment that includes:

• Physical symptom burden

• Rate of nutritional decline

• Cognitive changes

• Recent hospitalizations or ER visits^3,4

Improving Team Communication

Interdisciplinary teams require a common shorthand during case conferences and recertifications. Instead of using subjective terms such as "the patient is weaker," a documented KPS score provides greater specificity. For instance, documenting a shift from a 60 to a 40 clearly communicates that a patient has moved from needing occasional assistance to being largely bedbound and requiring professional nursing care.^1,2

Karnofsky Performance Scale vs. PPS

Many teams use the Palliative Performance Scale (PPS). Because the PPS was actually modeled after the Karnofsky framework, the two are very similar. The PPS adds extra dimensions such as intake and level of consciousness, which can be helpful in the final days of life.⁸

Research shows that KPS and PPS scores are highly correlated and often used interchangeably in prognostic models.^8,9 Some clinicians prefer the KPS for its simplicity, while others choose the PPS for the additional detail it provides regarding a patient's clinical state.

Another variation is the Australia-modified Karnofsky Performance Status (AKPS), which was adjusted to be more sensitive to changes in palliative care settings. Studies show strong agreement between the original KPS and the AKPS, meaning organizations can often choose the version that best fits their specific workflow.¹⁰

Putting KPS into Practice: An Example

The Karnofsky Performance Scale is most accurate when based on what a patient is actually doing, rather than what they "could" do. To maintain accuracy, clinicians should anchor their scores to observable behaviors.

Clinical Example:

Consider a patient with end-stage COPD. Two months ago, they could manage their own hygiene and light housework (KPS 70). Currently, they spend most of the day in a chair, require help with lower-body dressing, and need a shower chair and assistance with bathing. They can no longer perform any housework.

In this case, a score of 50 is appropriate. This reflects that the patient requires "considerable assistance and frequent medical care" and is no longer independent in self-care.^1,3

Using a downloadable PDF during the assessment process can help clinicians avoid "scoring drift," in which different staff members interpret percentages differently. A quick-reference tool ensures that "70" means the same thing to the admitting nurse as it does to the physician.

Limitations and Best Practices

While the Karnofsky Performance Scale is a helpful tool, it has limitations. It relies on clinician judgment, which can lead to variability if the team has not had consistent training.^6,7 Furthermore, a single score cannot capture the complexity of a patient’s pain, emotional state, or caregiver support system.

Function can also change due to temporary infections or medication changes. Therefore, the KPS is most powerful when viewed as a trend over time.^2,4 Tracking the score across multiple visits provides a clearer picture of the disease trajectory than any single measurement.

The strength of the Karnofsky Performance Scale is its ability to create a shared language. It helps teams describe what a patient can do, where they need help, and how their illness is progressing.^1,3 By incorporating this scale into regular documentation, organizations can improve the clarity of their clinical records and the quality of their care planning.

For organizations building educational content around hospice and palliative care workflows, the Karnofsky performance scale is also a strong fit for a downloadable PDF. A clear, well-designed reference sheet can support more consistent scoring, reinforce documentation habits, and give teams a quick tool they can return to during care planning and review.

References

1. National Cancer Institute. Definition of Karnofsky Performance Status
   https://www.cancer.gov/publications/dictionaries/cancer-terms/def/karnofsky-performance-status

2. Mehta A, et al. Using Admission Karnofsky Performance Status as a Guide for Discharge Disposition and End-of-Life Discussions in Hospitalized Patients with Serious Illness
   https://pmc.ncbi.nlm.nih.gov/articles/PMC8336248/

3. Centers for Medicare & Medicaid Services. LCD: Hospice Determining Terminal Status (L34538)
   https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=34538

4. SEER. Site-Specific Factor 3 | TNM Data
   https://staging.seer.cancer.gov/tnm/input/1.9/brain/ssf3/?breadcrumbs=(~schema_list~),(~view_schema~,~brain~)

5. Péus D, et al. Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation
   https://pmc.ncbi.nlm.nih.gov/articles/PMC3722041/

6. Lyons KD, et al. Reliability and Validity of the Functional Assessment of Chronic Illness Therapy-Palliative Care
   https://pmc.ncbi.nlm.nih.gov/articles/PMC2746408/

7. Ferreira PCDOSS, et al. Cross-cultural adaptation of the Karnofsky Performance Status scale and analysis of its reliability and validity
   https://pmc.ncbi.nlm.nih.gov/articles/PMC11665335/

8. Baik D, et al. Using the Palliative Performance Scale to Estimate Survival for Patients at the End of Life: A Systematic Review of the Literature
   https://pmc.ncbi.nlm.nih.gov/articles/PMC6211821/

9. de Kock I, et al. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and vice versa, in cancer patients
   https://pubmed.ncbi.nlm.nih.gov/24380215/

10. Abernethy AP, et al. The Australia-modified Karnofsky Performance Status (AKPS) scale
    https://pmc.ncbi.nlm.nih.gov/articles/PMC1308820/